Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02172625 · ClinicalTrials.gov registry record · NA

The Effect of Protandim Supplementation on Oxidative Damage and Athletic Performance

A NA study of Oxidative Stress, sponsored by University of Louisville.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02172625 is a NA study of Oxidative Stress that has completed, run by University of Louisville. The registered enrollment target is 40 participants, below the 85-participant average among 36 other Oxidative Stress trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02172625, a NA study of Oxidative Stress, has completed, sponsored by University of Louisville.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Nutrition supplementation with antioxidants have been discussed as a way to further enhance overall well-being of athletes, promote faster recovery, and improve overall performance. The use of Protandim, a nutritional supplement containing 5 botanicals (Bacopa extract 150 mg; milk thistle 225mg; ashwagandha 150 mg; green tea 75 mg; turmeric 75 mg) has shown promise in an earlier study by reducing oxidative stress and increasing the amount of the anti-oxidant enzymes in the blood. The purpose of this study was to examine the effect of \~90 day Protandim supplementation on 5-km running performance and on acute and long term oxidative damage as assessed by blood markers. Secondarily, another purpose of this study examined the effect of Protandim supplementation on other blood parameters (such as antioxidant enzyme concentrations) and measures of quality of life. The experiment was double-blind, placebo controlled. The study addressed two main questions and two secondary questions: Main Question 1: Does regular supplementation of Protandim (675 mg/day for 90 days) improve 5-km running times? Hypothesis: Protandim would improve 5-km running time by 0.5 min (SD 1-min). This is equivalent to an effect size of 0.5. The placebo group will have no change in performance. Main Question 2: Does regular supplementation of Protandim (675 mg/day for 90 days) reduce oxidative damage at rest as assessed by lipid peroxides (TBARS) in runners? Hypothesis: Based on the data by Nelson et al. (2006), oxidative damaged would be reduced by 40% (effect size = 4.8). Secondary Question 1: Does regular supplementation of Protandim (675 mg/day for 90 days) in runners reduce the increase in oxidative damage post-race compared to pre-race as assessed by lipid peroxides (TBARS)? Hypothesis: Based on the data by Kyparos et al. (2009), we expected a 45% increase in TBARS post-exercise compared to pre-exercise (effect size of 3.6). However, we expected that those that are on Protandim for 90 days

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Protandim Dietary Supplement
  • OTHER Placebo Group

Study Locations (1)

Kentucky

  • Crawford Gym, Room 17a, University of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2014-11
Est. Completion 2016-06
Phase NA

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT02172625

The ClinicalTrials.gov registry entry for NCT02172625 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 85-participant average among 36 other Oxidative Stress trials with a reported enrollment target (53% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Oxidative Stress appearing as the primary indexed condition, and to 2 interventions - of which Protandim Dietary Supplement is the first listed.

NCT02172625 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT02172625 about?

NCT02172625 is a clinical study titled "The Effect of Protandim Supplementation on Oxidative Damage and Athletic Performance". Nutrition supplementation with antioxidants have been discussed as a way to further enhance overall well-being of athletes, promote faster recovery, and improve overall performance. The use of Protandim, a nutritional supplement containing 5 botanicals (Bacopa extract 150 mg; milk thistle 225mg; ash...

What is the current status of trial NCT02172625?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-11. Estimated completion is 2016-06.

What conditions does trial NCT02172625 study?

This clinical trial studies the following conditions: Oxidative Stress.

What interventions are being tested in trial NCT02172625?

The interventions under investigation include: Protandim Dietary Supplement (DIETARY_SUPPLEMENT), Placebo Group (OTHER).

Who is sponsoring clinical trial NCT02172625?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02172625 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oxidative Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.